Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients
- 13 February 2006
- Vol. 39 (1) , 17-26
- https://doi.org/10.1016/j.bone.2005.12.003
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Sulfated Polysaccharides Enhance the Biological Activities of Bone Morphogenetic ProteinsJournal of Biological Chemistry, 2003
- Heparan Sulfate Proteoglycans Retain Noggin at the Cell SurfaceJournal of Biological Chemistry, 2002
- Genotype-phenotype correlation in hereditary multiple exostosesJournal of Medical Genetics, 2001
- Specificities of heparan sulphate proteoglycans in developmental processesNature, 2000
- The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfateProceedings of the National Academy of Sciences, 2000
- The Tumor Suppressor EXT-like Gene EXTL2 Encodes an α1, 4-N-Acetylhexosaminyltransferase That TransfersN-Acetylgalactosamine and N-Acetylglucosamine to the Common Glycosaminoglycan-Protein Linkage RegionJournal of Biological Chemistry, 1999
- The Putative Tumor Suppressors EXT1 and EXT2 Are Glycosyltransferases Required for the Biosynthesis of Heparan SulfateJournal of Biological Chemistry, 1998
- Mutation Screening of the EXT1 and EXT2 Genes in Patients with Hereditary Multiple ExostosesAmerican Journal of Human Genetics, 1997
- A gene for hereditary multiple exostoses maps to chromosome 19pHuman Molecular Genetics, 1994
- Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11Human Molecular Genetics, 1994